Copyright
©The Author(s) 2020.
World J Gastroenterol. Aug 7, 2020; 26(29): 4218-4239
Published online Aug 7, 2020. doi: 10.3748/wjg.v26.i29.4218
Published online Aug 7, 2020. doi: 10.3748/wjg.v26.i29.4218
Table 2 Tumor regrowth and salvage surgery in watch and wait clinical studies
| Study | Patients (n) | Regrowth | Salvage surgery | Distant metastasis | Survival |
| Habr-Gama et al[161] | 90 | 27 (31%) | 93% | 13 (14%) | 3 yr (88%) |
| Renehan et al[99] | 129 | 44 (34%) | 84% | 5 (4%) | 3 yr (96%) |
| Kong et al[162] | 370 | 105 (28.4%) | 83.80% | ||
| van der Valk et al[102] | 1000 | 250 (25%) | 86% | 80 (8%) | 5 yr (85%) |
| Chadi et al[165] | 602 | 168 (28%) | 89% | 60 (10%) | 5 yr (87%) |
| Dattani et al[100] | 692 | 149 (21.6%) | 88% | 56 (8.2%) | 3 yr (93.5%) |
| On et al[164] | 248 | 37 (15.3%) | 68.40% | 8 (21%) | 92.30% |
| Nasir et al[160] | 78 | 23 (29.5%) | 100% | 1 (4.35%) | 3 yr (96%) |
- Citation: López-Campos F, Martín-Martín M, Fornell-Pérez R, García-Pérez JC, Die-Trill J, Fuentes-Mateos R, López-Durán S, Domínguez-Rullán J, Ferreiro R, Riquelme-Oliveira A, Hervás-Morón A, Couñago F. Watch and wait approach in rectal cancer: Current controversies and future directions. World J Gastroenterol 2020; 26(29): 4218-4239
- URL: https://www.wjgnet.com/1007-9327/full/v26/i29/4218.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i29.4218